Digital pathology slide analysis (AISight platform).
FDA cleared (AISight platform).
Not the primary source used here.
Official Labcorp press release confirming a NATIONWIDE expansion of PathAI deployment across its network — Labcorp, not PathAI, is the source, making this a stronger than usual third-party confirmation of scale.
Nationwide expansion confirmed at Labcorp, one of the largest US clinical laboratory networks.
Confirm whether ‘nationwide’ refers to full rollout or a phased expansion before quoting the figure precisely.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.